Skip to main content
. 2022 Dec 30;56:101805. doi: 10.1016/j.eclinm.2022.101805

Fig. 4.

Fig. 4

Kaplan–Meier survival curves of disease progression-free survival for the VAT-RM in the training cohort (A) and total test cohort (B). The median value of the high-risk subgroup was 30 months and low-risk subgroup was not reached in the training cohort with a significant difference (P < 0.0001), and the median value of the high-risk subgroup was 43 months and low-risk subgroup was not reached in total test cohort with a significant difference (P < 0.0001). Kaplan–Meier survival curve of adverse outcome-free survival for the SAT-RM in the training cohort (C) and total test cohort (D). The median value of the high-risk subgroup was 28 months and low-risk subgroup was not reached in training cohort with a significant difference (P < 0.0001), and the median value of the high-risk subgroup was 53 months and low-risk subgroup was not reached in total test cohort with a significant difference (P = 0.0004). (RM, radiomics model; SAT, subcutaneous adipose tissue; VAT, visceral adipose tissue).